Lyndon Lien
Keine laufenden Positionen mehr
Karriereverlauf von Lyndon Lien
Ehemalige bekannte Positionen von Lyndon Lien
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KINDRED BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 05.02.2021 | 27.08.2021 |
Independent Dir/Board Member | 05.02.2021 | 27.08.2021 | |
ALZA CORPORATION | Direktor/Vorstandsmitglied | - | - |
Balance Therapeutics, Inc.
Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Direktor/Vorstandsmitglied | 01.01.2009 | - |
Vorstandsvorsitzender | 01.01.2009 | - | |
Gründer | 01.01.2009 | - | |
Präsident | 01.01.2009 | - |
Ausbildung von Lyndon Lien
MIT Sloan School of Management | Masters Business Admin |
Harvard University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Director/Board Member | 3 |
Chief Executive Officer | 1 |
Founder | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Balance Therapeutics, Inc.
Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Health Technology |
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Kindred Biosciences, Inc.
Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA. | Health Technology |
- Börse
- Insiders
- Lyndon Lien
- Erfahrung